| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |